JPRN-UMIN000027014已完成未知
The follow up study of "Phase l / ll Study of S-1+oxaliplatin (SOX)+cetuximab as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild type (JACCRO CC-06)". - JACCRO CC-06 B
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Synchronous multiple malignancy or metachronous multiple malignancy within 5 years disease free interval. (2) Symptomatic brain metastases. (3) Severe infectious disease. (4) Interstitial lung disease or pulmonary fibrosis. (5) Comorbidity or history of heart failure. (6) Sensory alteration or paresthesia interfering with function. (7) Large quantity of pleural, abdominal or cardiac effusion. (8) Severe comorbidity (renal failure, liver failure, hypertension, etc). (9) Prior radiotherapy for primary and metastases tumors. (10) Men/women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. Women with a positive pregnancy test. (11) History of severe allergy. (12) History of allergy for L-OHP and other platinating agent. (13) Prior treatment of cetuximab or L-OHP or TS-1. (14) Administration of flucytosine. (15) Any other cases who are regarded as inadequate for study enrollment by investigators.
研究者
相似试验
已完成
不适用
An accompanying research for the Phase II study of nivolumab + bevacizumab + paclitaxel in patients with HER2-negative metastatic breast cancer:WJOG9917B(WJOG9917BTR)HER2-negative metastatic breast cancerJPRN-UMIN000029590West Japan Oncology Group51
进行中（未招募）
1 期
ong-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal FistulaPerianal fistulising Crohn´s diseaseMedDRA version: 20.0Level: PTClassification code 10002156Term: Anal fistulaSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2019-000333-39-FRMillennium Pharmaceuticals, Inc (MPI)150
进行中（未招募）
1 期
ong-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal FistulaPerianal fistulising Crohn´s diseaseMedDRA version: 20.0Level: PTClassification code 10002156Term: Anal fistulaSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2019-000333-39-CZTakeda Development Center Americas, Inc150
进行中（未招募）
1 期
ong-term Follow-up Study With Darvadstrocel in the Treatment of Complex PerianalFistulaPerianal fistulising Crohn´s diseaseMedDRA version: 20.0Level: PTClassification code 10002156Term: Anal fistulaSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2019-000333-39-HUMillennium Pharmaceuticals, Inc (MPI)150
进行中（未招募）
1 期
ong-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal FistulaPerianal fistulising Crohn´s diseaseMedDRA version: 20.0Level: PTClassification code 10002156Term: Anal fistulaSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2019-000333-39-ITMILLENNIUM PHARMACEUTICALS, INC.150